Zenna is an AI-powered health-tech startup specializing in brainwave modulation sound technology to support individuals experiencing migraines and headache-related sensitivities. Founded in 2024 by University of Cambridge alumnus Moon Yin, the company is headquartered in London, United Kingdom. Zenna's mission is to provide personalized, non-invasive wellness solutions accessible through a mobile application and standard headphones, aiming to empower individuals to manage their well-being without relying solely on traditional medications.
Key Strategic Focus
Zenna's strategic focus centers on developing and delivering non-invasive, drug-free solutions for migraine and headache management. The company's core objectives include:
- Personalized Wellness Support: Offering tailored experiences to users through proprietary sound technology that modulates brainwaves using dynamic frequencies such as theta binaural beats (4–8 hertz), white noise, and Tibetan singing bowls.
- Accessibility and Convenience: Ensuring that the solution is easily accessible via a mobile app and compatible with everyday headphones, allowing users to experience relief anytime and anywhere.
- Scientific Validation: Collaborating with healthcare professionals and academic institutions to conduct extensive clinical testing, with over 5,000 participants reporting an 85% positive experience in supporting headache and migraine wellness.
Financials and Funding
Zenna is a privately held company operating in the health-tech sector. While specific funding details are not publicly disclosed, the company is supported by notable European health-tech accelerators:
- Zinc VC: A London-based venture builder known for supporting mission-driven, science-led startups addressing complex challenges in health and the environment.
- Paris&Co: A premier innovation hub in Paris that accelerates the growth of startups in the healthcare sector, providing strategic partnerships across Europe.
These partnerships provide Zenna with invaluable support, including access to a global network of health-tech leaders, scientists, and hands-on guidance across key areas such as regulatory strategy.
Pipeline Development
Zenna's primary product is its mobile application that delivers brainwave modulation sound technology designed to support migraine and headache wellness. The solution has undergone early clinical evaluation through pilot studies with public hospitals, providing promising evidence of its potential impact. The company continues to collaborate with healthcare professionals and academic research institutions to refine and enhance the product, with future developments focusing on personalized sound experiences tailored to individual user needs.
Technological Platform and Innovation
Zenna's innovation lies in its proprietary brainwave modulation sound technology, which utilizes dynamic frequencies to influence brainwave activity. Key aspects include:
- Proprietary Technologies: The use of theta binaural beats, white noise, and Tibetan singing bowls to modulate brainwaves, offering a non-invasive method for managing migraines and headaches.
- Scientific Methodologies: The technology is grounded in neuroscience research and has been developed in collaboration with leading public hospitals and academic institutions, ensuring a research-backed approach to wellness support.
Leadership Team
Zenna's leadership team comprises experts from world-renowned institutions, bringing a wealth of experience in business, technology, and healthcare:
- Moon Yin – Chief Executive Officer: A University of Cambridge alumnus with extensive experience in digital product development and the startup ecosystem. His personal experience with chronic migraines inspired the creation of Zenna's non-invasive, science-backed solution.
- Sean Chuang – Chief Product Officer: With over 14 years of product leadership experience at companies like Zendesk, Transdev, Hulu, and Dollar Shave Club, Sean focuses on merging human-centered design with science-driven wellness to create accessible digital health experiences.
- Dr. Shujhat Khan – Science Advisor: An NHS medical doctor with advanced training in neurosurgery and emergency medicine, educated at the University of Cambridge and Imperial College London. Dr. Khan brings significant experience in clinical trials and neurotechnology to Zenna.
- Dr. Cem Gokhan – Medical Advisor: A practicing GP registrar and Honorary Clinical Lecturer at University College London, with a strong background in emergency and primary care. Dr. Gokhan ensures that Zenna's solutions are both effective and user-friendly.
Competitor Profile
Zenna operates in the digital health and wellness industry, focusing on non-invasive solutions for migraine and headache management. The market is characterized by a growing demand for alternative therapies and personalized health solutions. Key competitors include:
- Cefaly: Offers an FDA-approved external trigeminal nerve stimulation device for migraine prevention and treatment.
- Migraine Buddy: A mobile application that helps users track migraines and identify triggers, providing personalized insights.
- Nerivio: Provides a wearable device that uses remote electrical neuromodulation to treat migraines.
Zenna differentiates itself by offering a non-invasive, sound-based solution that is easily accessible through a mobile app and standard headphones, emphasizing personalization and scientific validation.
Strategic Collaborations and Partnerships
Zenna's collaborations with Zinc VC and Paris&Co strengthen its market position and innovation capacity. These partnerships provide access to a global network of health-tech leaders, scientists, and strategic guidance, facilitating the company's growth and development in the digital health sector.
Operational Insights
Zenna's strategic considerations include:
- Market Position: Positioning itself as a leader in non-invasive, sound-based migraine and headache management solutions.
- Competitive Advantages: Offering a personalized, accessible, and scientifically validated solution that differentiates from traditional medication-based treatments and other non-invasive devices.
- Innovation Capacity: Continuous collaboration with healthcare professionals and academic institutions to refine and enhance the product, ensuring it meets the evolving needs of users.
Strategic Opportunities and Future Directions
Zenna's strategic roadmap includes:
- Product Enhancement: Developing personalized sound experiences tailored to individual user needs, enhancing the effectiveness of the solution.
- Market Expansion: Leveraging partnerships to expand into new markets and reach a broader audience seeking non-invasive migraine and headache management solutions.
- Research and Development: Investing in ongoing research to explore additional applications of brainwave modulation sound technology in other areas of mental health and wellness.
Contact Information
- Website: Zenna Official Website
